Your session is about to expire
← Back to Search
Coconut Oil for Mouth Sores
Phase 2
Recruiting
Led By Courtney Huddle, MSN, RDN, LDN
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients planning to undergo myeloablative conditioning regimens in preparation for HSCT
ECOG Performance Status of less than or equal to 2 or Lansky/Karnofsky Performance Status of greater than or equal to 50 within 7 days prior to date of enrollment
Must not have
Planned discharge home prior to engraftment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 45
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a mouth rinse made from virgin coconut oil can help prevent painful mouth sores in young patients receiving intense treatment. The coconut oil is thought to help by calming and reducing inflammation in the mouth.
Who is the study for?
This trial is for pediatric patients aged 7 to 26 years who are about to receive high-dose chemotherapy and have no current mouth sores. They must be able to perform mouth rinses, not have tree nut allergies, and not be using other non-standard oral care regimens or coconut oil rinses recently.
What is being tested?
The study tests if virgin coconut oil (VCO) can prevent mouth sores when added to standard oral care rinses in children receiving intense chemotherapy. The severity of mouth sores with VCO will be compared against those using only the standard treatment.
What are the potential side effects?
While the side effects aren't detailed here, potential risks may include allergic reactions for those sensitive to coconut products. Generally, VCO is considered safe with minimal risk of adverse effects when used as a rinse.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am preparing for a stem cell transplant with intensive treatment.
Select...
I can care for myself and am up more than 50% of my waking hours.
Select...
I do not have any sores in my mouth.
Select...
I am between 7 and 26 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I will be going home before my new cells start to grow.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 45
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 45
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Severity of Mucositis
Secondary study objectives
Average Daily Caloric Intake
Daily Incidence of Optional Mouth Rinses
Days to Absolute Neutrophil Count (ANC) Engraftment
+5 moreOther study objectives
Oral Rinse Utilization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of care + virgin coconut oilExperimental Treatment1 Intervention
Arm A: Standard of care + virgin coconut oil
Group II: Standard of CareActive Control1 Intervention
Arm B: Standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coconut oil
Not yet FDA approved
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for mouth sores, such as Virgin Coconut Oil (VCO), work primarily through their anti-inflammatory and antimicrobial properties. The anti-inflammatory action helps to reduce swelling, pain, and redness associated with mouth sores, providing relief and promoting healing.
The antimicrobial properties help to prevent or reduce infection by targeting harmful bacteria and other pathogens that can exacerbate sores. These mechanisms are crucial for mouth sore patients as they not only alleviate symptoms but also prevent complications, leading to faster recovery and improved oral health.
Oropharyngeal Decontamination with Antiseptics to Prevent Ventilator-Associated Pneumonia: Rethinking the Benefits of Chlorhexidine.A better definition of counselling strategies is needed to define effectiveness in temporomandibular disorders management.Treatment of oral malodour. Medium-term efficacy of mechanical and/or chemical agents: a systematic review.
Oropharyngeal Decontamination with Antiseptics to Prevent Ventilator-Associated Pneumonia: Rethinking the Benefits of Chlorhexidine.A better definition of counselling strategies is needed to define effectiveness in temporomandibular disorders management.Treatment of oral malodour. Medium-term efficacy of mechanical and/or chemical agents: a systematic review.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,397 Previous Clinical Trials
2,460,070 Total Patients Enrolled
Courtney Huddle, MSN, RDN, LDNPrincipal InvestigatorWake Forest University Health Sciences
Courtney Huddle, MSN, RDN, CSPCC, LDNPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I use special mouthcare products not listed in the standard plan and intend to keep using them.I had a stem cell transplant within the last 3 months.I am preparing for a stem cell transplant with intensive treatment.I have used coconut oil mouth rinses in the last 30 days.I can care for myself and am up more than 50% of my waking hours.I, and if applicable, my caregiver, can follow the study's procedures throughout its duration.I can swish and spit medicine as my doctor thinks is okay.I do not have any sores in my mouth.I will be going home before my new cells start to grow.I am between 7 and 26 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of care + virgin coconut oil
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger